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The incredible leaps in technology that now make high-speed genome sequencing possible are revolutionizing
the hunt for genes and genetic variations associated with disease. A stunning series of recent genome-wide
association studies (GWAS) have identified new candidate genes for a number of common diseases including
breast cancer, heart disease, diabetes type I and II, obesity, Crohn’s disease, multiple sclerosis, glaucoma,
and asthma. This Genomics Select highlights several of the most recent GWAS and also explores how a
genome-wide approach can be used to address intriguing questions in cell and molecular biology.
A Clean Sweep through the Genome
High-resolution GWAS enable at least half-a-million single nucleotide polymorphisms (SNPs, the most common form
of genetic variants) to be compared between individuals with a particular disease and control subjects (case-control
cohorts) or between family trios (affected child and both parents) and controls. Rigorous statistical analyses then
identify those SNPs that are ‘‘overtransmitted’’ in affected individuals (transmission disequilibrium) and hence
mark a particular gene or short genomic region as being associated with the presence or risk of a particular disease.
In contrast to traditional candidate-gene approaches, such unbiased genome sweeps are more likely to identify new
genes not suspected of association with a particular disease. Several of the most recent GWAS are highlighted here.
In their study of more than 1000 patients with type I diabetes and their fam-
ilies, Hakonarson et al. (2007) identified significant association of three variants
in the KIAA0350 gene on chromosome 16p13 with type I diabetes. This gene
encodes a putative sugar-binding C-type lectin and is expressed predomi-
nantly in cells of the immune system including dendritic cells, B cells, and nat-
ural killer cells. The authors propose that the product of the KIAA0350 gene
could be involved in antigen presentation, although it will take much more re-
search to decipher how variations in this gene could contribute to the autoim-
mune destruction of insulin-producing pancreatic b cells, the cause of type I
diabetes. This work confirms KIAA0350’s association with type I diabetes
identified in a detailed analysis of two GWAS by Todd et al. (2007). The Todd
et al. analysis also identified several other chromosomal loci associated with
type I diabetes containing genes such asPTPN22 (encoding a T cell protein ty-
rosine phosphatase) andCD226 (encoding a T cell costimulation factor), bring-
ing to ten the number of genes implicated in this autoimmune disease.
Tackling genetic risk factors for one of the leading causes of death, Samani et al. (2007) analyzed two GWAS in sev-
eral thousand Europeans with coronary artery disease and case controls. They confirmed associations of several chro-
mosomal loci (9p21.3, 6q25.1, and 2q36.3) with coronary artery disease and myocardial infarction. The 9p21.3 region
is particularly intriguing because it encodes two cyclin-dependent kinase inhibitors (p16INK4a and p15INK4b) that are
key players in cell-cycle regulation and have been implicated in atherosclerosis (a known cause of heart disease)
through regulation of the growth factor TGF-b. Meanwhile, studying another common cause of cardiac arrest, atrial
fibrillation, Gudbjartsson and colleagues (2007) identify two sequence variants in chromosomal region 4q25 that are
strongly associated with atrial fibrillation in Icelandic, European, and Chinese populations. Intriguingly, both variants
are very close to the PITX2 gene, the product of which is known to regulate asymmetric development of the heart.
Indeed, deletion of PITX2 interferes with formation of the sino-atrial node in the left atrium.
Plumbing the genetic riches of the Icelandic population, Thorleifsson et al.
(2007) identify two coding SNPs as strong risk factors for the blinding eye
disease, exfoliation glaucoma. The SNPs are located in the coding region of
the LOXL1 gene, which encodes a lysyl oxidase known to be involved in
the formation of elastin fibers. Each SNP is predicted to lead to an amino
acid switch that could alter the catalytic activity or substrate specificity of
LOXL1 leading to aberrant production of elastin fibers and accumulation of
fibrillar material that could cause the build up of eye pressure characteristic
of glaucoma.
Finally, Hafler et al. (2007) tackle a debilitating neurological disease, multiple
sclerosis, and in a tour-de-force GWAS of more than 300,000 SNPs in 931
affected families, they identify SNPs in the genes encoding interleukin-2 recep-
tor-a and interleukin-7 receptor-a as risk factors for multiple sclerosis. Interleu-
kin-2 and its receptor are important for regulating T cell responses; indeed, var-
iants in interleukin-2 receptor-a have been implicated in other autoimmune
diseases, including type I diabetes and Graves disease (hyperthyroidism). Inter-
leukin-7 and its receptor are required for maintaining the memory T cell pool and
for development of g and d T cells (found in the inflammatory lesions of multiple sclerosis patients); the disease
SNP is predicted to introduce a coding change that may alter the ratio of soluble to membrane-bound interleukin-7
receptor. Although the single strongest genetic risk factor for multiple sclerosis remains HLA-DRB1 and the risk
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contributed by the two interleukin receptor variants is low, this work does open up new avenues for elucidating the
pathogenesis of this disease.
These studies, together with more than 15 others, provide a big step forward in identifying unsuspected genes and
their variants associated with a number of common diseases. However, an even bigger challenge will be to convert
these tantalizing genetic insights into a firm understanding of disease pathogenesis enabling the identification of new
therapeutic targets and the development of new treatments.
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Parthenogenesis under Wraps
An unusual application of genome-wide SNP analysis is reported by Daley
and colleagues (Kim et al., 2007), who use this approach to prove that
a human embryonic stem (ES) cell line was derived by parthenogenesis in-
stead of somatic cell nuclear transfer (SCNT). Human ES cell lines are usually
derived from excess embryos generated by in vitro fertilization, but they can
also be produced by SCNT, in which a nucleus from a mature somatic cell is
inserted into a donor oocyte that has had its own nucleus removed. SCNT
has been touted as a viable method for producing patient-specific human
ES cells, although, to date, claims of success have proven to be erroneous.
A third method for generating human ES cell lines that has received less at-
tention is parthenogenesis, which involves artificial activation of an oocyte in
the absence of fertilization, resulting in development of an embryo based en-
tirely on the maternal genome. Daley and colleagues apply genome-wide
SNP analysis to elucidate whether a human ES cell line (SCNT-hES-1) claimed to have been generated by SCNT
could instead have been derived by parthenogenesis. The authors demonstrate convincingly that the patterns of
SNP homozygosity and heterozygosity in SCNT-hES-1 cells are very similar to those of mouse ES cell lines known
to have been derived parthenogenetically. They next examined the methylation status of differentiated SCNT-hES-1
cells at three imprinted gene loci, one normally methylated on the paternal genome and the other two normally meth-
ylated on the maternal genome. They show that the two maternally imprinted loci were fully methylated indicative of
the SCNT-hES-1 cells having two maternal genomes, whereas the paternally imprinted locus was predominantly un-
methylated, suggesting a missing paternal genome. Together, these data demonstrate that the SCNT-hES-1 cell line
claimed to be generated by SCNT was in fact produced through parthenogenetic development of the donor oocyte,
which had retained its nucleus during the SCNT procedure. The approach of Daley and coworkers could be applied
in the future to discern the correct origin of human ES cell lines generated using the same donor for both the oocyte
and the somatic cell nucleus. The authors also propose that parthenogenetically derived human ES cell lines might
provide a useful source of tissue for research and perhaps even transplantation as long as such tissues that lack
methylation of paternally imprinted genes prove to be functional and free of growth abnormalities.
K. Kim et al. (2007). Cell Stem Cell. 10.1016/j.stem.2007.07.001.
Chromatin Profiling Made Easy
A key characteristic of ES cells is that they can be induced to leave their pluripotent state and differentiate into one of
many different cell lineages. Each of the steps along the lineage commitment pathway is believed to reflect a different
chromatin state regulated by a suite of modifications (most notably methylation) to histones and other proteins. Now
Mikkelsen et al. (2007) apply a clever method to derive detailed genome-wide maps of the distribution of chromatin
modifications in three mouse stem cell lines at different stages of lineage commitment. The method (ChIP-Seq) com-
bines chromatin immunoprecipitation (ChIP) of DNA with single molecule sequencing using a high-speed Illumina/
Solexa sequencer to map ChIP enrichment. The authors examined five different methylation patterns of histone H3
and H4 in mouse ES cells, neural progenitor cells, and embryonic fibroblasts and obtained genome-wide chromatin
distribution maps for each pattern in each cell type. They found that particular patterns of trimethylation of H3 and
H4 lysine residues could be used as markers to identify, for example, primary coding and noncoding transcripts
(trimethylation of H3 lysine 36) or repetitive elements (trimethylation of lysine 9 in H3 and lysine 20 in H4). Importantly,
a bivalent marker (trimethylation of H3 lysines 4 and 27) seemed to reflect retention of pluripotency, with loss of the
bivalent mark associated with differentiation. These genome-wide maps of chromatin state yield insights into gene
expression potential and cell differentiation state that go beyond information obtained by more traditional methods
such as RNA expression profiling.
T.S. Mikkelsen et al. (2007). Nature 448, 553.
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